Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;
Ann Hepatol. 2024;29:
O-18 DIFFERENCES IN BODY COMPOSITION OF MAFLD PATIENTS ACCORDING TO BODY MASS INDEX AND METABOLIC PROFILE
Eva Juárez; Iván López; Karen Bernal; Alain Velázquez; Andrea Maldonado; Martha Helena Ramos; Misael Uribe; Graciela Castro;
Ann Hepatol. 2024;29 Supl 1:
Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms
Xiaoyi Wang; Zhen Yang; Ying Ran; Long Li; Bangmao Wang; Lu Zhou;
Ann Hepatol. 2023;28: